Novel targeted approaches in non-small cell lung cancer (NSCLC).
Ardizzoni
A
A
Azienda Ospedaliera-Universitaria, Parma, Italy. aardizzoni@ao.pr.it
Tiseo
M
M
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; C512478:EGFR protein, human; D066246:ErbB Receptors